(Q35788112)

10 August 2017

1 reference

title

The anti-angiogenic basis of metronomic chemotherapy (English)

1 reference

10 August 2017

1 reference

angiogenesis inhibitor

1 reference

Robert S Kerbel

1

1 reference

PubMed ID

15170445

10 August 2017

Barton A Kamen

series ordinal

2

1 reference

PubMed ID

15170445

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

10 August 2017

Nature Reviews Cancer

1 reference

10 August 2017

4

1 reference

10 August 2017

6

1 reference

10 August 2017

423-436

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1369

10 August 2017

0 references

cites work

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

Metronomic scheduling: the future of chemotherapy?

21 January 2018

1 reference

Mathematics and oncology: a match for life?

21 January 2018

1 reference

Dosing study seen as victory for clinical trials, mathematical models.

21 January 2018

1 reference

Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors.

21 January 2018

1 reference

Phase II study of weekly docetaxel in patients with metastatic breast cancer

21 January 2018

1 reference

Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.

21 January 2018

1 reference

Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis.

21 January 2018

1 reference

A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy.

21 January 2018

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

21 January 2018

1 reference

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

21 January 2018

1 reference

Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study

21 January 2018

1 reference

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

21 January 2018

1 reference

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

Role of endothelial cell survival and death signals in angiogenesis

21 January 2018

1 reference

Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.

21 January 2018

1 reference

Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor

21 January 2018

1 reference

Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor

21 January 2018

1 reference

Low dose carboplatin combined with angiostatic agents prevents metastasis in human testicular germ cell tumor xenografts

21 January 2018

1 reference

Effect of p53 status on tumor response to antiangiogenic therapy.

21 January 2018

1 reference

Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly

21 January 2018

1 reference

Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere).

21 January 2018

1 reference

Thrombospondins and tumor angiogenesis

21 January 2018

1 reference

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

21 January 2018

1 reference

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

21 January 2018

1 reference

Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors

21 January 2018

1 reference

Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors.

21 January 2018

1 reference

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

21 January 2018

1 reference

The combination of chemotherapy and systemic immunotherapy and the concept of cure in murine leukemia and lymphoma

21 January 2018

1 reference

Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy

21 January 2018

1 reference

Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.

21 January 2018

1 reference

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

21 January 2018

1 reference

Evaluation of long-term daily administration of oral low-dose etoposide in elderly patients with relapsing or refractory non-Hodgkin's lymphoma

21 January 2018

1 reference

Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma

21 January 2018

1 reference

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma

21 January 2018

1 reference

21 January 2018

Oral delivery of taxanes

1 reference

Combined effects of angiostatin and ionizing radiation in antitumour therapy

21 January 2018

1 reference

Phase I and II trials of novel anti-cancer agents: endpoints, efficacy and existentialism. The Michel Clavel Lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998.

21 January 2018

1 reference

Angiogenesis modulation in cancer research: novel clinical approaches

21 January 2018

1 reference

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

21 January 2018

1 reference

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications

21 January 2018

1 reference

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

21 January 2018

1 reference

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

21 January 2018

1 reference

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

21 January 2018

1 reference

High-time chemotherapy or high time for low dose

31 March 2020

1 reference

Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic

31 March 2020

1 reference

High-dose chemotherapy for breast cancer: the French PEGASE experience

31 March 2020

1 reference

Docetaxel administered on a weekly basis for metastatic breast cancer

31 March 2020

1 reference

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

31 March 2020

1 reference

Redefining the target: chemotherapeutics as antiangiogenics

31 March 2020

1 reference

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

31 March 2020

1 reference

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

31 March 2020

1 reference

Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression

31 March 2020

1 reference

A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens

31 March 2020

1 reference

Treatment of non-small-cell lung cancer with prolonged oral etoposide

31 March 2020

1 reference

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

31 March 2020

1 reference

Treatment of children and young adults with early-stage non-Hodgkin's lymphoma

31 March 2020

1 reference

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

31 March 2020

1 reference

Topical application of methotrexate for inhibition of corneal angiogenesis

31 March 2020

1 reference

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate

31 March 2020

1 reference

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

31 March 2020

1 reference

Could less be more? Low-dose chemotherapy goes on trial

31 March 2020

1 reference

Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma

31 March 2020

1 reference

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

31 March 2020

1 reference

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

31 March 2020

1 reference

Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells

31 March 2020

1 reference

Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells

31 March 2020

1 reference

Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents

31 March 2020

1 reference

Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

31 March 2020

1 reference

Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses

31 March 2020

1 reference

Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose

31 March 2020

1 reference

CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs

31 March 2020

1 reference

Taxane-mediated antiangiogenesis in vitro: influence of formulation vehicles and binding proteins

31 March 2020

1 reference

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

31 March 2020

1 reference

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

31 March 2020

1 reference

Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis

31 March 2020

1 reference

Tumor response to radiotherapy regulated by endothelial cell apoptosis

31 March 2020

1 reference

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

31 March 2020

1 reference

Epoetin for cancer patients: a boon or a danger?

31 March 2020

1 reference

Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis

31 March 2020

1 reference

High time for low‐dose prospective clinical trials

31 March 2020

1 reference

Immunomodulating anticancer alkylating drugs: targets and mechanisms of activity

31 March 2020

1 reference

Of what value is uracil/tegafur plus leucovorin to colorectal cancer patients?

31 March 2020

1 reference

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

31 March 2020

1 reference

Inhibition of angiogenesis by non-toxic doses of temozolomide

31 March 2020

1 reference

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

31 March 2020

1 reference

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

31 March 2020

1 reference

Metronomic therapy for breast cancer

31 March 2020

1 reference

Anti-angiogenic chemotherapy in central nervous system tumors.

31 March 2020

1 reference

Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1369

1 reference

10 August 2017

1 reference

PubMed ID

15170445